JPRN-UMIN000008530已完成未知
Randomized, open-label study to compare the effect of the compounds of inhaled corticosteroid and long-acting beta2 agonist on pulmonary function and symptomatic control in association with inspiratory flow in elderly patients with bronchial asthma. - Randomized, open-label study to compare the effect of the compounds of inhaled corticosteroid and long-acting beta2 agonist on pulmonary function and symptomatic control in association with inspiratory flow in elderly patients with bronchial asthma.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Contraindication to budesonide/formoterol or fluticasone /salmeterol compound. 2. High-dose ICS/LABA have already been prescribed (Symbicot(R) inhalation>=6 times/day or Adair(R) 500 inhalation). 3. Respiratory infection in last 4 weeks before enrollment. 4. Beta2 agonist in any form. 5. Systemic corticosteroid therapy in last 30 days before enrollment. 6. Any serious comorbidity. 7. Being or willing to be pregnant 8. Investigator judged as inappropriate for this study.
研究者
相似试验
进行中（未招募）
1 期
An open-label study to compare the effectiveness of FF/UMEC/VI using the Connected Inhaler System with FP/SAL plus tiotropium in participants with inadequately controlled asthmaEUCTR2017-001532-19-NLGlaxoSmithKline Research & Development Ltd1,006
进行中（未招募）
不适用
A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of SchizophreniaSchizophreniaEUCTR2007-003342-15-HUEli Lilly and Company Limited580
进行中（未招募）
1 期
A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia - HGMTSchizophreniaEUCTR2007-003342-15-FREli Lilly and Company Limited580
进行中（未招募）
1 期
A Randomized, Open-Label Study Comparing the Effects of Olanzapine Pamoate Depot with Oral Olanzapine on Treatment Outcomes in Outpatients with Schizophrenia - HGLQSchizophreniaEUCTR2005-004157-99-SKEli Lilly and Company Limited520
进行中（未招募）
不适用
A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of SchizophreniaSchizophreniaEUCTR2007-003342-15-GBEli Lilly and Company Limited580